124 related articles for article (PubMed ID: 9584264)
21. Isovaleric acidemia. Clinical features of a new genetic defect of leucine metabolism.
Budd MA; Tanaka K; Holmes LB; Efron ML; Crawford JD; Isselbacher KJ
N Engl J Med; 1967 Aug; 277(7):321-7. PubMed ID: 4378266
[No Abstract] [Full Text] [Related]
22. [Carnitine in the treatment of methylmalonic aciduria (MMA)].
Penn D; Schmidt H; Otten A; Schmidt-Sommerfeld E
Monatsschr Kinderheilkd; 1986 Oct; 134(10):758-61. PubMed ID: 2879226
[TBL] [Abstract][Full Text] [Related]
23. [Isovaleric acidemia: identical biochemical picture in 3 patients with variable clinical manifestations].
Bakkeren JA; Sengers RC; Ruitenbeek W; Trijbels JM; Houben ML; Van der Zeè SP
Tijdschr Kindergeneeskd; 1982 Oct; 50(5):153-9. PubMed ID: 7157337
[TBL] [Abstract][Full Text] [Related]
24. Alloisoleucine in isovaleric acidaemia.
Rabier D; Parvy P; Bardet J; Saudubray JM; Kamoun P
J Inherit Metab Dis; 1992; 15(1):154-5. PubMed ID: 1583870
[No Abstract] [Full Text] [Related]
25. 3-Hydroxy-3-methylglutaric aciduria: response to carnitine therapy and fat and leucine restriction.
Dasouki M; Buchanan D; Mercer N; Gibson KM; Thoene J
J Inherit Metab Dis; 1987; 10(2):142-6. PubMed ID: 2443756
[TBL] [Abstract][Full Text] [Related]
26. The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidaemia.
Böhles H; Lehnert W
Eur J Pediatr; 1984 Nov; 143(1):61-3. PubMed ID: 6510434
[TBL] [Abstract][Full Text] [Related]
27. Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.
Huidekoper HH; Schneider J; Westphal T; Vaz FM; Duran M; Wijburg FA
J Inherit Metab Dis; 2006 Oct; 29(5):631-6. PubMed ID: 16972171
[TBL] [Abstract][Full Text] [Related]
28. Amino-acid depletion induced by abnormal amino-acid conjugation and protein restriction in isovaleric acidemia.
Loots DT; Mienie LJ; Erasmus E
Eur J Clin Nutr; 2007 Nov; 61(11):1323-7. PubMed ID: 17299485
[TBL] [Abstract][Full Text] [Related]
29. Hyperammonaemia in a preterm infant with isovaleric acidaemia.
Wilson WG; Audenaert SM; Squillaro EJ
J Inherit Metab Dis; 1984; 7(2):71. PubMed ID: 6434830
[No Abstract] [Full Text] [Related]
30. Involvement of erythrocyte calpain in glycine- and carnitine-treated isovaleric acidemia.
Salamino F; Di Lisa F; Burlina AB; Menabŏ R; Barbato R; De Tullio R; Siliprandi N
Pediatr Res; 1994 Aug; 36(2):182-6. PubMed ID: 7970932
[TBL] [Abstract][Full Text] [Related]
31. Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy.
Gimenes AC; Bravo DM; Nápolis LM; Mello MT; Oliveira AS; Neder JA; Nery LE
Braz J Med Biol Res; 2015 Apr; 48(4):354-62. PubMed ID: 25714882
[TBL] [Abstract][Full Text] [Related]
32. Carnitine therapy and metabolism in the disorders of propionyl-CoA metabolism studied using 1H-NMR spectroscopy.
Davies SE; Iles RA; Stacey TE; de Sousa C; Chalmers RA
Clin Chim Acta; 1991 Dec; 204(1-3):263-77. PubMed ID: 1819469
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of isovaleric acidaemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme.
Abdenur JE; Chamoles NA; Guinle AE; Schenone AB; Fuertes AN
J Inherit Metab Dis; 1998 Aug; 21(6):624-30. PubMed ID: 9762597
[TBL] [Abstract][Full Text] [Related]
34. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups.
Roe CR; Hoppel CL; Stacey TE; Chalmers RA; Tracey BM; Millington DS
Arch Dis Child; 1983 Nov; 58(11):916-20. PubMed ID: 6651329
[TBL] [Abstract][Full Text] [Related]
35. Chronic intermittent form of isovaleric acidemia mimicking diabetic ketoacidosis.
Erdem E; Cayonu N; Uysalol E; Yildirmak ZY
J Pediatr Endocrinol Metab; 2010 May; 23(5):503-5. PubMed ID: 20662350
[TBL] [Abstract][Full Text] [Related]
36. Isovaleric acidemia: Therapeutic response to supplementation with glycine, l-carnitine, or both in combination and a 10-year follow-up case study.
Chinen Y; Nakamura S; Tamashiro K; Sakamoto O; Tashiro K; Inokuchi T; Nakanishi K
Mol Genet Metab Rep; 2017 Jun; 11():2-5. PubMed ID: 30547004
[TBL] [Abstract][Full Text] [Related]
37. Effects of L- and DL-carnitine on patients with impaired exercise tolerance.
Watanabe S; Ajisaka R; Masuoka T; Yamanouchi T; Saitou T; Toyama M; Takeyasu N; Sakamoto K; Sugishita Y
Jpn Heart J; 1995 May; 36(3):319-31. PubMed ID: 7650839
[TBL] [Abstract][Full Text] [Related]
38. l-Carnitine Supplementation in Recovery after Exercise.
Fielding R; Riede L; Lugo JP; Bellamine A
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29534031
[TBL] [Abstract][Full Text] [Related]
39. L-Carnitine insufficiency in disorders of organic acid metabolism: response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3-methylglutaric aciduria.
Chalmers RA; Stacey TE; Tracey BM; de Sousa C; Roe CR; Millington DS; Hoppel CL
J Inherit Metab Dis; 1984; 7 Suppl 2():109-10. PubMed ID: 6207380
[No Abstract] [Full Text] [Related]
40. Effect of L-carnitine on the physical fitness of thalassemic patients.
El-Beshlawy A; El Accaoui R; Abd El-Sattar M; Gamal El-Deen MH; Youssry I; Shaheen N; Hamdy M; El-Ghamrawy M; Taher A
Ann Hematol; 2007 Jan; 86(1):31-4. PubMed ID: 17031691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
